Overview

A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer

Status:
Unknown status

Trial end date:
2019-05-01

Target enrollment:

Participant gender:

Summary

This study is designed to compare the three chemotherapy regimens(TEGAFOX Sequential S-1 or SOX Sequential S-1 or SOX non-Sequential S-1) for postoperative patients with gastric cancer, observe and record the efficacy and tolerance,to evaluate which regimen is better.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

LanZhou University

Treatments:

Oxaliplatin